Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15026160rdf:typepubmed:Citationlld:pubmed
pubmed-article:15026160lifeskim:mentionsumls-concept:C0752124lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C1705493lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C0018591lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C0022341lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C1522410lld:lifeskim
pubmed-article:15026160lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:15026160pubmed:issue2lld:pubmed
pubmed-article:15026160pubmed:dateCreated2004-3-17lld:pubmed
pubmed-article:15026160pubmed:abstractTextThe highest prevalence rate of spinocerebellar ataxia type 6 (SCA6) in the worldwide population is in the Chugoku and Kansai areas of Western Japan, but the reason of this geographic characteristics is unclear. We investigated the predisposing haplotypes and their geographic distribution. Genotyping of five microsatellite markers and three single nucleotide polymorphisms linked to the CACNA1A gene in 150 Japanese SCA6 patients from unrelated 118 families revealed three major haplotypes, carrying a pool of one common haplotype core. A founder chromosome was thought to have historically diverged into at least three types. One of the major haplotypes newly identified showed a strong geographical cluster around the Seto Inland Sea in the Chugoku and Kansai areas of Western Japan, whereas the others were widely distributed throughout Japan. The distribution of predisposing haplotypes contributes to the geographical differences in prevalence of SCA6.lld:pubmed
pubmed-article:15026160pubmed:languageenglld:pubmed
pubmed-article:15026160pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15026160pubmed:citationSubsetIMlld:pubmed
pubmed-article:15026160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15026160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15026160pubmed:statusMEDLINElld:pubmed
pubmed-article:15026160pubmed:monthMarlld:pubmed
pubmed-article:15026160pubmed:issn0304-3940lld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:MatsumotoMasa...lld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:OdaMasayaMlld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:MorinoHiroyuk...lld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:MaruyamaHirof...lld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:TerasawaHideo...lld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:IzumiYuishinYlld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:KawakamiHides...lld:pubmed
pubmed-article:15026160pubmed:authorpubmed-author:MiyachiTakafu...lld:pubmed
pubmed-article:15026160pubmed:issnTypePrintlld:pubmed
pubmed-article:15026160pubmed:day25lld:pubmed
pubmed-article:15026160pubmed:volume358lld:pubmed
pubmed-article:15026160pubmed:ownerNLMlld:pubmed
pubmed-article:15026160pubmed:authorsCompleteYlld:pubmed
pubmed-article:15026160pubmed:pagination107-10lld:pubmed
pubmed-article:15026160pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:meshHeadingpubmed-meshheading:15026160...lld:pubmed
pubmed-article:15026160pubmed:year2004lld:pubmed
pubmed-article:15026160pubmed:articleTitleA novel haplotype of spinocerebellar ataxia type 6 contributes to the highest prevalence in western Japan.lld:pubmed
pubmed-article:15026160pubmed:affiliationDepartment of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima 734-8551, Japan.lld:pubmed
pubmed-article:15026160pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15026160pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:773entrezgene:pubmedpubmed-article:15026160lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15026160lld:entrezgene
lhgdn:association:10553lhgdn:found_inpubmed-article:15026160lld:lhgdn